权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mapping & quantifying lymphatic drainage of the arm's alternate pathway

测绘

基本信息

批准号：
10533807
负责人：
Dhruv Singhal
金额：
$ 43.4万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-01-26 至 2025-12-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10533807
关键词：
Affect Anatomy Area Attention Axilla Axillary Lymph Node Dissection Axillary lymph node group Back Bilateral Breast Cancer Patient Breast Cancer Treatment Breast Cancer survivor Cadaver Cancer Survivorship Circulation Clinical Data Development Disease Dissection Dyes Event Fatigue Female Goals Hand High-Risk Cancer Imaging Techniques Indocyanine Green Infection Injury Life Lymph Lymphatic Lymphatic System Lymphatic function Lymphedema Lymphography Malignant Female Reproductive System Neoplasm Malignant Neoplasms Maps Measures Medical Methods Modeling Modernization Operating Rooms Operative Surgical Procedures Pain Pathway interactions Patient risk Patients Physical therapy Population Positive Lymph Node Prevention Procedures Prospective Studies Quality of life Radiation Risk Risk Factors Scanning Secondary to Skin Cancer Symptoms Testing Time Tissues United States Upper Extremity Upper arm Urologic Cancer Variant Woman arm arm function cost fluorophore high risk individual variation innovation intraoperative optical imaging lymphatic drainage lymphoscintigraphy malignant breast neoplasm novel nuclear imaging operation prevent preventive intervention sarcoma standard care temporal measurement treatment strategy volunteer

项目摘要

Project Summary/Abstract Breast Cancer Related Lymphedema affects 1.2 million patients in the United States and has no cure. The symptoms of lymphedema include fatigue, tightness, pain, and life-threatening infections. However, two-thirds of women undergoing breast cancer treatment with the highest risk factors for developing lymphedema do not develop the disease. While there is no explanation for this finding, one hypothesis is that normal anatomic variations of the lymphatic system pre-dispose certain women to developing lymphedema after breast cancer treatment. Specifically, the main back-up lymphatic pathway of the arm, the Mascagni-Sappey (MS) pathway, is variably present in cadaver studies and avoids areas that are usually damaged with breast cancer treatment. Moreover, when present in these cadaver studies, the MS pathway has variable anatomic connections which can impact its ability to drain the arm effectively. We hypothesize that, utilizing modern imaging techniques, we can define the anatomy of the MS pathway and its variations in normal women and in breast cancer survivors who have undergone high risk breast cancer treatment and did not develop lymphedema. Utilizing this information, we will be able to predict which variations predispose women to develop lymphedema. Finally, we will develop a novel method of non-invasive intra- operative optical imaging to assess the function of this pathway during breast cancer operations to predict the patient's risk of developing lymphedema. The ability to evaluate real-time lymphatic function would allow cancer teams to implement preventive interventions in high risk patients. As the most common cause of lymphedema in the United States is secondary to cancer procedures, this model of lymphedema prevention could be widely applied to the treatment of other high risk cancer populations including gynecologic cancers, urologic cancers, skin cancers, and sarcomas.

项目总结/文摘